Home
Free Trial
Free TrialSign In
  • Sign In
  • What we do
    • Countries/Macro
      • Global Economic Model
      • Global Macro Service
      • Global Trade Flows
      • Global Scenarios
      • Country Economic Forecasts
      • US Forecasts
      • Africa Forecasts
      • Event-Driven Analysis
      • All services
    • Cities & Regions
      • Global
      • UK & Europe
      • Americas
      • Africa & Middle East
      • Asia-Pacific
    • Industries
      • Global Industry Service
      • Global Construction Service
    • CONSULTANCY
      • Economic Impact
      • Thought Leadership
      • Macro Consulting
      • Bespoke Forecasting
    • TRAVEL & TOURISM
      • Global Travel Service
      • Global City Travel
      • Air Passenger Forecasts
      • Webinars
      • Resources
      • Careers
      • Awards
    • Contact us to find out more about our forecasting services, models, & scenarios.

      Free trial
  • How we help

    Our economists and analysts help organisations make better decisions, set strategies, improve resiliency, establish policy, discover new opportunities, optimize operations and plan for growth. Find out how we can help you below or use our product recommendation tool to get started.

    • TRENDING TOPICS
      • Presidential election
      • Coronavirus
      • Coronavirus vaccine
      • Climate change
      • Cities
      • Our approach
      • How we help
      • Sectors we serve
      • Blog
  • About Us
  • My Oxford
  • Contact
  • Media
  • Sectors We Serve
  • My sector
    • How we help
      • Asset Management
      • B2C
      • Banking
      • Chemicals
      • Energy
      • Government
      • Infrastructure
      • Manufacturing
      • Mining
      • Real Estate
      • Technology
      • Travel and tourism

Coronavirus updates

Understand the economic impact of the coronavirus.

Already a client? Login here

Featured Coronavirus Research Briefings

Global | Coronavirus Watch: Early lessons from Israel

18 Jan 2021 - The speedy vaccine rollout in Israel means that the majority of the most vulnerable to Covid-19 there may soon enjoy peak protection from the virus.

Read more

Global | For world trade, a strong but incomplete rebound in 2021

11 Jan 2021 - World goods trade recovered strongly in the second half of 2020 and by mid2021 should be expanding at a double-digit annual pace.

Read more

Global | Coronavirus Watch: Optimism surge proves short lived

11 Jan 2021 - The sense of optimism at the prospect of widespread vaccinations in 2021 has been deflated by the discovery of more transmissible forms of coronavirus in the UK and South Africa, as well as the stuttering start to vaccination programmes in some advanced economies.

Read more

US | A low neutral policy rate with a 1% handle

06 Jan 2021 - What was once considered a floor, may now represent a ceiling for the nominal neutral policy rate (r*).

Read more

UK | New lockdown set to push UK back into recession

05 Jan 2021 - We expect the introduction of a third lockdown to cause GDP to fall more than 4% q/q in Q1.

Read more

UK | Tougher restrictions take a toll on high frequency data

05 Jan 2021 - According to the latest high-frequency data the economic respite offered by the lifting of the England-wide lockdown in November has proved short-lived.

Read more

Global | Coronavirus Watch: Inflation – this time isn’t different

04 Jan 2021 - The prospect of large shares of some economies’ populations being vaccinated in the first half of 2021, supporting a return to some degree of normality, has stoked renewed concerns that inflation could pick up sharply this year.

Read more

Global | Coronavirus Watch: Three key vaccine uncertainties

14 Dec 2020 - Over the past month, we have revised up our global GDP growth forecast for 2021 to 5.2% from 4.9%. We also see a more favourable balance of risks around our forecast. But considering the significant impact of vaccine developments, what might prompt us to become even more optimistic?

Read more

Global | Vaccine optimism reduces EM risks

10 Dec 2020 - The positive developments on Covid-19 vaccines are broadly in line with our baseline forecast for emerging markets – we expect a noticeable impact from mass vaccination programs from around mid 2021.

Read more

Global | Coronavirus Watch: Industry’s strength to endure

07 Dec 2020 - The latest PMI data suggest that the activity hit from lockdowns and tighter restrictions in November won’t be sufficient to prompt another contraction in global growth and that the industrial sector continues to perform strongly.

Read more

Want to keep up to date on the latest economic impacts of the coronavirus? Click here to subscribe to our blog.

About Oxford Economics

Oxford Economics is a leader in global forecasting and quantitative analysis. Our worldwide client base comprises more than 1,500 international corporations, financial institutions, government organisations, and universities.

Headquartered in Oxford, with offices around the world, we employ 400 staff, including 250 economists and analysts. Our best-in-class global economic and industry models and analytical tools give us an unmatched ability to forecast external market trends and assess their economic, social and business impact.

Register for a free trial

  • Oxford Economics
    • About us
    • Contact us
    • Media
    • Economists and analysts
    • Careers
  • Products and services
    • Subscription services
    • Economic impact
    • Thought leadership
  • Help and software
    • Help using our services
    • Software and downloads
    • Latest technology developments
  • Privacy and Legal
    • Privacy policy
    • Cookies
    • Data protection
    • Terms and conditions
    • Software Support and Training
  • Follow Us
    • LinkedIn
    • Twitter
    • Facebook
© Oxford Economics 2020 all rights reserved